GE Aerospace sales soar 25% as jet engine demand hits new highs
GE Aerospace (NYSE:GE) reported a powerful start to 2026, with double-digit growth across its commercial and defense segments.
GE Aerospace (NYSE:GE) reported a powerful start to 2026, with double-digit growth across its commercial and defense segments.
Hancock Whitney (NASDAQ:HWC) announced its financial results for the first quarter of 2026, characterized by a sequential decline in net income following a record-breaking end to 2025.
Federal Signal (NYSE:FSS), a leader in environmental and safety solutions, announced today that its Board of Directors has declared a quarterly cash dividend of $0.15 per share on its common stock.
Northern Trust (NASDAQ:NTRS) reported a powerful start to the fiscal year, with first-quarter net income jumping to $525.5 million, or $2.71 per diluted share.
Southern First Bancshares (NASDAQ:SFST), the holding company for Southern First Bank, delivered a record-setting performance for the first quarter of 2026.
Northrop Grumman (NYSE:NOC) delivered a robust financial performance for the first quarter of 2026, driven by sustained global demand for its advanced defense technologies.
Laser Photonics (NASDAQ:LASE), a leading global developer of industrial laser systems for cleaning and material processing, reported a significant step-up in scale for the fourth quarter and fiscal year ended December 31, 2025.
United Community Banks (NYSE:UCB) delivered a strong opening to 2026, reporting double-digit revenue growth and expanding profit margins.
Sow Good (NASDAQ:SOWG) announced a transformative strategic shift today, entering into a definitive agreement to acquire 100% of the Tanzanian subsidiaries holding the Nachu Graphite Project.
Peoples Bancorp (NASDAQ:PEBO), the parent company of Peoples Bank, announced today that it has entered into a definitive merger agreement to acquire Citizens National in a transaction valued at approximately $76.6 million.
Merck (NYSE:MRK) Eisai announced today that their Phase 3 LITESPARK-012 trial failed to meet its dual primary endpoints, a disappointing result for the pharmaceutical partners’ attempt to establish a new standard of care in first-line kidney cancer treatment.
Atlantic Union Bankshares (NYSE:AUB) reported a strong start to 2026, delivering quarterly earnings that exceeded analyst expectations as the company finalized the integration of its acquisition of Sandy Spring Bancorp.